The estimated Net Worth of Robert N Cavanaugh is at least $1.47 Million dollars as of 3 September 2024. Mr Cavanaugh owns over 1,569 units of Accolade stock worth over $763,341 and over the last 10 years he sold ACCD stock worth over $22. In addition, he makes $706,125 as Pres at Accolade.
Mr has made over 52 trades of the Accolade stock since 2020, according to the Form 4 filled with the SEC. Most recently he exercised 1,569 units of ACCD stock worth $6,135 on 3 September 2024.
The largest trade he's ever made was exercising 18,821 units of Accolade stock on 11 June 2024 worth over $73,590. On average, Mr trades about 1,069 units every 22 days since 2015. As of 3 September 2024 he still owns at least 195,228 units of Accolade stock.
You can see the complete history of Mr Cavanaugh stock trades at the bottom of the page.
Robert Cavanaugh is the Pres at Accolade.
As the Pres of Accolade, the total compensation of Mr Cavanaugh at Accolade is $706,125. There are 1 executives at Accolade getting paid more, with Rajeev Singh having the highest compensation of $828,000.
Mr Cavanaugh is 52, he's been the Pres of Accolade since . There are 3 older and 2 younger executives at Accolade. The oldest executive at Accolade, Inc. is J. Michael Cline, 60, who is the Co-Founder & Independent Chairman.
Robert's mailing address filed with the SEC is , C/O ACCOLADE, INC., SEATTLE, WA, 98101.
Over the last 4 years, insiders at Accolade have traded over $9,006,680 worth of Accolade stock and bought 74 units worth $743 . The most active insiders traders include Edgar Jr Bronfman, Jeffrey D Jordan und Dawn G Lepore. On average, Accolade executives and independent directors trade stock every 5 days with the average trade being worth of $18,928. The most recent stock trade was executed by Rajeev Singh on 3 September 2024, trading 3,786 units of ACCD stock currently worth $14,803.
Accolade, Inc., together with its subsidiaries, develops and provides technology-enabled solutions that help people to understand, navigate, and utilize the healthcare system and their workplace benefits in the United States. The company offers a platform with cloud-based technology and multimodal support from a team of health assistants and clinicians, including nurses, physician medical directors, and behavioral health specialists. It also provides second opinion consultation and health care decision support services. The company serves employers who provide their employees and their employees' families a single place to turn for their health, healthcare, and benefits needs. Accolade, Inc. was incorporated in 2007 and is headquartered in Plymouth Meeting, Pennsylvania.
Accolade executives and other stock owners filed with the SEC include: